CVE-2026-123218: IBM Aspera Faspex (Critical, CVSS 9.8)
- CVSS
- 9.8 Critical (v3.1)
- EPSS
- 0.4% chance of exploitation in the next 30 days (higher than 34.1% of CVEs)
- Exploited in the wild
- Yes, on CISA’s KEV list since Nov 9, 2026
- Public exploit
- None reported in public exploit databases
- Weakness
- CWE-863
- Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H- Published
- Nov 7, 2026
- CISA fix-by date
- Nov 12, 2026 (for US federal agencies)
What it is
IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.
Description from the National Vulnerability Database.
What to do
CISA: Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating
Check whether you run IBM Aspera Faspex, then apply the vendor’s fix or mitigation from the advisories below. Because this flaw is exploited or has public exploit code, treat it as urgent and check for signs of compromise, not just the patch level.
Sources: NVD, FIRST EPSS, CISA KEV, and public exploit databases (availability only). ThreatRoundup reports whether public exploit code exists but never links to it: fake proof-of-concepts that infect security researchers are common. This page updates automatically.